{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:55:28Z","timestamp":1795226128578,"version":"4.10.3"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study developed a nomogram using computed tomography (CT)-based delta-radiomics features and clinicopathological factors to predict lymph node metastasis (LNM) in patients with esophageal squamous cell carcinoma (ESCC) receiving neoadjuvant chemoradiotherapy (nCRT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study retrospectively enrolled 170 patients with ESCC receiving nCRT. The delta-radiomics signature model was constructed utilizing least absolute shrinkage and selection operator regression, and the radiomics score (radScore) was determined for each patient. A combined nomogram was established using the radScore and independent influencing factors obtained through univariate and multivariate analyses. The consistency and predictive ability of the nomogram were assessed using the calibration curve and the area under the receiver operating factor curve (AUC). The clinical benefits were assessed using decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Two predictive models were constructed. The AUC values for the delta-radiomics signature model were 0.881 [95% confidence interval (CI): 0.827\u20130.935]. According to the univariate and multivariate analyses, the tumor length, tumor differentiation, and radScore were independent factors influencing LNM (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). A combined nomogram was constructed from these factors, and the AUC reached 0.938 (95% CI: 0.898\u20130.979). DCA demonstrated that the clinical benefits of the nomogram for patients across an extensive range were more significant than the radiomics model alone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This CT-based delta-radiomics nomogram model could benefit LNM in patients with ESCC following nCRT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_712_25","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:00:28Z","timestamp":1767189628000},"page":"1245-1252","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["CT-based delta-radiomics nomogram for predicting post-neoadjuvant chemoradiotherapy lymph node metastasis in esophageal squamous cell carcinoma: A feasibility study"],"prefix":"10.4103","volume":"21","author":[{"given":"Bin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingshuo","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Center, Yantai Affiliated Hospital of Binzhou Medical University, The 2Medical College of Binzhou Medical University, Yantai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrui","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260102","first-page":"229","article-title":"Global cancer statistics 2022:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260102","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","article-title":"Comparative analysis of cancer statistics in China and the United States in 2024","volume":"137","author":"Wu","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R3-20260102","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS):Long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"R4-20260102","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010):A Phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"key":"R5-20260102","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/SLA.0000000000001594","article-title":"Esophageal cancer:Associations with (pN+) lymph node metastases","volume":"265","author":"Rice","year":"2017","journal-title":"Ann Surg"},{"key":"R6-20260102","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/SLA.0b013e3181b2f6ee","article-title":"Optimum lymphadenectomy for esophageal cancer","volume":"251","author":"Rizk","year":"2010","journal-title":"Ann Surg"},{"key":"R7-20260102","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/SLA.0000000000003598","article-title":"Value of lymphadenectomy in patients receiving neoadjuvant therapy for esophageal adenocarcinoma","volume":"274","author":"Raja","year":"2021","journal-title":"Ann Surg"},{"issue":"37","key":"R8-20260102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpg.2018.11.009","article-title":"Novel imaging techniques in staging oesophageal cancer","volume":"36","author":"Foley","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R9-20260102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10388-019-00704-w","article-title":"Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET","volume":"17","author":"Shuto","year":"2020","journal-title":"Esophagus"},{"key":"R10-20260102","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00330-018-5583-z","article-title":"The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer","volume":"29","author":"Qu","year":"2019","journal-title":"Eur Radiol"},{"key":"R11-20260102","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.21037\/jtd.2018.10.57","article-title":"Systematic review and meta-analysis of the accuracy of 18F-FDG PET\/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma","volume":"10","author":"Jiang","year":"2018","journal-title":"J Thorac Dis"},{"key":"R12-20260102","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00330-017-4935-4","article-title":"Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio","volume":"28","author":"Liu","year":"2018","journal-title":"Eur Radiol"},{"key":"R13-20260102","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2214\/ajr.144.2.261","article-title":"Normal mediastinal lymph nodes:Number and size according to American Thoracic Society mapping","volume":"144","author":"Glazer","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"R14-20260102","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40364-023-00480-x","article-title":"Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy","volume":"11","author":"Cui","year":"2023","journal-title":"Biomark Res"},{"key":"R15-20260102","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/thorax-2023-220226","article-title":"Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches","volume":"79","author":"Warkentin","year":"2024","journal-title":"Thora\u00d7"},{"key":"R16-20260102","doi-asserted-by":"crossref","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","article-title":"Radiomics in breast cancer:Current advances and future directions","volume":"5","author":"Qi","year":"2024","journal-title":"Cell Rep Med"},{"key":"R17-20260102","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics:The bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"R18-20260102","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12967-024-05392-4","article-title":"CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients","volume":"22","author":"Fan","year":"2024","journal-title":"J Transl Med"},{"key":"R19-20260102","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/cancers14010241","article-title":"Delta-radiomics predicts response to first-line oxaliplatin-based chemotherapy in colorectal cancer patients with liver metastases","volume":"14","author":"Giannini","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R20-20260102","doi-asserted-by":"crossref","first-page":"990608","DOI":"10.3389\/fonc.2022.990608","article-title":"Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"key":"R22-20260102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0284185120980144","article-title":"Detecting lymph node metastasis of esophageal cancer on dual-energy computed tomography","volume":"63","author":"Sun","year":"2022","journal-title":"Acta Radiol"},{"key":"R23-20260102","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.tranon.2018.04.005","article-title":"Building CT radiomics based nomogram for preoperative esophageal cancer patients lymph node metastasis prediction","volume":"11","author":"Shen","year":"2018","journal-title":"Transl Oncol"},{"key":"R24-20260102","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00330-018-5581-1","article-title":"Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma","volume":"29","author":"Tan","year":"2019","journal-title":"Eur Radiol"},{"key":"R25-20260102","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/RCT.0000000000001125","article-title":"Predicting lymph node metastasis using computed tomography radiomics analysis in patients with resectable esophageal squamous cell carcinoma","volume":"45","author":"Zhao","year":"2021","journal-title":"J Comput Assist Tomogr"},{"key":"R26-20260102","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11547-024-01853-4","article-title":"Delta radiomics:An updated systematic review","volume":"129","author":"Nardone","year":"2024","journal-title":"Radiol Med"},{"key":"R27-20260102","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s00261-023-03910-4","article-title":"MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer","volume":"48","author":"Fang","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"R28-20260102","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1007\/s00330-023-10241-x","article-title":"Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"34","author":"Han","year":"2024","journal-title":"Eur Radiol"},{"key":"R29-20260102","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12885-025-13678-z","article-title":"Delta dual-region DCE-MRI radiomics from breast masses predicts axillary lymph node response after neoadjuvant therapy for breast cancer","volume":"25","author":"Zeng","year":"2025","journal-title":"BMC Cancer"},{"key":"R30-20260102","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to radiomics","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J Nucl Med"},{"key":"R31-20260102","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"R32-20260102","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/SLA.0000000000001902","article-title":"Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer?","volume":"264","author":"Heneghan","year":"2016","journal-title":"Ann Surg"},{"key":"R33-20260102","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1572-0241.2004.30692.x","article-title":"Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection","volume":"99","author":"Agarwal","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R34-20260102","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SLA.0000000000004798","article-title":"Impact of lymph node dissection on survival after neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma:From the results of NEOCRTEC5010, a randomized multicenter study","volume":"277","author":"Guo","year":"2023","journal-title":"Ann Surg"},{"key":"R35-20260102","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1097\/SLA.0000000000005450","article-title":"Lymph node ratio improves prediction of overall survival in esophageal cancer patients receiving neoadjuvant chemoradiotherapy:A National Cancer database analysis","volume":"277","author":"Zhang","year":"2023","journal-title":"Ann Surg"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_712_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:45Z","timestamp":1786647405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_712_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_712_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-04-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}